Interview with Meredith Priddy of Rx Remedies, Inc — CBD Oils
Airing on December 20th at 7pm EST.
At Rx Remedies, Inc., we believe in doing things right. Though this industry has no regulatory oversight, we hold ourselves to the highest standards with pharmaceutical-grade manufacturing and pharmacologist formulations. Our objective is to create the most effective, plant-based remedies on the market for combating pain, inflammation, anxiety, stress, depression, and insomnia.
We formed Rx Remedies, Inc. to redefine the true meaning of medicine by creating 100% plant-based products backed by medicinal science. Although the majority of our products include full-spectrum CBD, our formulations go beyond the therapeutic benefits of any single ingredient. We include multiple, plant-based, active ingredients in each and every product, all for relieving pain, inflammation, anxiety, stress, depression, and insomnia. Our mission is to help people take control of their own health through our pharmacologist-formulated, plant-based remedies.
Rx Remedies includes a highly experienced medical team. Our expertise ensures the pharmaceutical-grade formulation of all products, as each ingredient used is purposeful and intentional. Our Chief Science Officer is a board-certified toxicologist and pharmacologist with over a decade of experience in cannabis research.
We craft our products with the utmost precision, all active ingredients are supported by medicinal science, and all active ingredients are included at higher concentrations for maximum absorption. We aren’t just making CBD products. We’re creating the most effective, plant-based remedies for combating systemic pain, inflammation, anxiety, stress, depression, and insomnia.
With Decades of Collective Experience, Meet the Rx Remedies Team:
John Powers, Ph.D., MBA, Chief Executive Officer — B.S. in microbiology and Ph.D. from the University of Maryland School of Medicine with a MBA from the University of Maryland. John has 30+ years experience in start-up companies, pharmaceutical manufacturing, medical product development, and FDA clinical trials experience.
James Tracy Taylor, PhD, DABT (Diplomate Am. Board of Toxicology), Chief Science Officer — B.S. in biology and chemistry with a M.S. in neuroscience, and a Ph.D. in pharmacology from Tulane University. Pharmacologist and board-certified toxicologist with over a decade of experience in cannabis research. Tracy developed the company’s proprietary formulations for all products.
Brent Berisford, M.S., Chief Business Development Officer — B.S. in chemistry and biology with a M.S. in environmental science from West Virginia University. Brent has an unparalleled ability to connect business and people.
Meredith Priddy, Chief Marketing Officer — B.S. in English and business writing from Towson University with a decade of experience in the cannabis industry. Develops and coordinates the company’s new products, plus tends to all sales and marketing efforts
Daniel Powers, MBA, Chief Operations Officer — B.S. in business administration with a MBA from Shenandoah University. Experienced in FDA regulated medical device manufacturing, accounting systems, operations, and inventories.
R. Hartman “Hart” Roemer, Esq., General Counsel — University of Delaware undergraduate and school of law. Admitted in MD, former Assistant Attorney General. Three decades legal experience in small company development, and corporate tax knowledge
Djeni Sidibe, Laboratory Director — A.A.S. in Biotechnology from Baltimore City Community College, with a B.S. in biology and chemistry from Notre Dame of Maryland University. Manages the lab and manufacturing processes, following cGMP guidelines and FDA regulations.
Harriett Kamendi, Ph.D. — B.S. in education, physics, chemistry and biology with a Ph.D. in pharmacology from Howard University. Assists with pharmacological development and researches metabolic pathways and neuro-chemistry of cannabinoids. Harriet is ntegral to clinical trials.M
Kathleen Kennedy, Ph.D. — B.S. in biology with a Ph.D. in genetics from Penn State University College of Medicine. Professor, Dir. Life Sciences Institute at the University of Maryland BioPark. Kathleen has 40+ years experience as a professor and biotechnology development training, and she is integral in the clinical trials and employee scientific training
Daniel Zang, Ph.D., Esq. — Patent attorney, medical product development, biotechnology & FDA specialist. Responsible for intellectual properties, legal matters, and FDA submissions.
